AMX0035, Radicava ORS Costs Could Cloud Therapies’ Benefits: ICER
When added to standard of care, both the experimental oral therapy AMX0035 and the U.S.-approved Radicava ORS oral suspension provide comparable or greater benefits to amyotrophic lateral sclerosis (ALS) patients than standard care alone. However, they won’t be cost-effective if priced like Radicava (edaravone), an approved, into-the-vein ALS…